Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c clinical trials

Explore recruiting limb girdle muscular dystrophy type r5 previously named lgmd2c clinical trials.

Also recruiting in Europe

Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I/II, open-label, dose escalation study to evaluate the safety of 2 doses of intravenous ATA-200, an adeno-associated viral vector carrying the human gamma-sarcoglycan gene, in patients with gamma-sarcoglycanopathy (limb-girdle muscular dystrophy LGMDR5, formerly LGMD2C).

France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c trials by city

Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Toronto Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Vancouver Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Montreal Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Calgary Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Edmonton Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Ottawa Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Winnipeg Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Quebec City Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Hamilton Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Kitchener Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in London Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Halifax Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in New York Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Los Angeles Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Chicago Limb Girdle Muscular Dystrophy Type R5 Previously Named Lgmd2c in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease